<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.inveslogic.com">
<channel>
 <title>Blog Articles Tagged with &#039;pfe&#039; at http://www.inveslogic.com</title>
 <link>http://www.inveslogic.com/tags/pfe</link>
 <description>Blog Articles Tagged with &#039;pfe&#039; at http://www.inveslogic.com</description>
 <language>en</language>
<item>
 <title>Five Things Worth Remembering About Healthcare in 2009</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149838?rsstype=tag&amp;tag=pfe</link>
 <description>Looking back through 2008, the Healthcare sector has hit some huge hurdles. Patent concerns and expirations were worries for all major firms, the Department of Justice hit Med Tech with fines, Big Pharma made thousands of job cuts, Managed Care got d...</description>
 <pubDate>Tue, 23 Dec 2008 13:41:09 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149838?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>40 Top Rated Emerging Bio-Pharma Stocks</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149841?rsstype=tag&amp;tag=pfe</link>
 <description>The accompanying table (click to enlarge) highlights the Top 40 Rated stocks (sorted alphabetically) in the ETF Innovators ((ETFI)) Emerging Bio-Pharma Index of biotech and pharmaceutical companies with market caps of $200M-$1.5B. The rating system f...</description>
 <pubDate>Tue, 23 Dec 2008 03:28:46 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149841?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Healthcare: Investing Trends for 2009</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149582?rsstype=tag&amp;tag=pfe</link>
 <description>Healthcare investing trends in 2009 and beyond will be affected by the new administration&#039;s plans for healthcare reform, which are summarized at the Change.gov website. A key feature of the plan is making health insurance coverage possible for all Am...</description>
 <pubDate>Fri, 19 Dec 2008 05:42:26 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149582?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>More Biotech Layoffs: Bristol-Myers Squibb, Entremed Feel the Pain</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149586?rsstype=tag&amp;tag=pfe</link>
 <description>I   m told by several people that Tuesday Bristol-Myers Squibb (BMY) is announcing layoffs in research (and perhaps other areas). I don   t know how extensive these are, or how they   re spread across the New Jersey and Connecticut sites. What I do k...</description>
 <pubDate>Wed, 17 Dec 2008 05:58:39 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149586?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Three Potential Biotech Takeover Targets</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149083?rsstype=tag&amp;tag=pfe</link>
 <description>Wednesday on CNBC&#039;s Fast Money show, it was noted that Big Pharma companies are sitting on piles of cash (read: billion$ and billion$), fueling speculation that M&amp;A activity in the drug sector will probably happen soon due to the depressed stock pric...</description>
 <pubDate>Fri, 05 Dec 2008 04:44:57 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149083?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Will Merck&#039;s Atherosclerosis Drug Fare Better Than Pfizer&#039;s Did?</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149091?rsstype=tag&amp;tag=pfe</link>
 <description>Ever since the catastrophic failure of Pfizer&#039;s (PFE) HDL-raising CETP inhibitor torcetrapib in late 2006, everyone involved has wondered just what the problem was. There was a definitely higher cardiovascular-linked death rate in the drug-treatment ...</description>
 <pubDate>Wed, 03 Dec 2008 01:41:37 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1149091?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Stocks Offering &#039;Healthy&#039; Returns</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1148783?rsstype=tag&amp;tag=pfe</link>
 <description>Abbott Labs (ABT) is a consistent performer with diversified healthcare operations, including pharmaceuticals, diagnostics, medical nutrition products, and medical devices/stents. ABT is back to the lower end of its trading range near 50 bucks, prese...</description>
 <pubDate>Tue, 25 Nov 2008 13:47:49 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1148783?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Pharmas and Biotech: Vying for Outsize Insulin Profits</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1148501?rsstype=tag&amp;tag=pfe</link>
 <description>Nektar Therapeutics (NKTR) has been struggling since 2007, when Pfizer (PFE) discontinued selling Nektar&#039;s Exubera inhaled insulin because of disappointing sales. Then Novartis (NVS) stepped in and bought Nektar   s pulmonary medicine delivery system...</description>
 <pubDate>Thu, 20 Nov 2008 14:09:21 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1148501?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Ultra Brite Outlook for Colgate - Barron&#039;s</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1147947?rsstype=tag&amp;tag=pfe</link>
 <description>Colgate-Palmolive (CL) is a relative latecomer to the downturn; shares have tumbled almost 25% over the past month as investors fret its once-touted exposure to emerging markets. Barron&#039;s notes that shares - $63 - trade at the same level as 1999, des...</description>
 <pubDate>Sun, 16 Nov 2008 10:27:26 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1147947?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>General Electric Moves On Down the Largest Company List</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1146308?rsstype=tag&amp;tag=pfe</link>
 <description>Below we highlight the 25 largest companies in the US.   As shown, Exxon Mobil (XOM) still holds the top spot, but there have been lots of other changes since the bear market started last October.   General Electric (GE) has probably had the most dra...</description>
 <pubDate>Wed, 12 Nov 2008 03:12:45 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1146308?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Market Update: Roche/Genentech Deal, AstraZeneca&#039;s New Statin, Yahoo, Microsoft Deal?</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1145580?rsstype=tag&amp;tag=pfe</link>
 <description>Biotech Mega-DealRoche (RHHBY.PK) has affirmed its intentions of buying the remaining 44% of Genentech (DNA) that it does not already own for $43.7B or $89 per share, which DNA rejected earlier this summer as undervaluing the company.A Paradigm Shift...</description>
 <pubDate>Mon, 10 Nov 2008 14:23:20 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1145580?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Rigel Pharmaceuticals: Biotech Crisis or Opportunity?</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1145376?rsstype=tag&amp;tag=pfe</link>
 <description>The past two weeks were anything but easy for Rigel   s (RIGL) shareholders, who saw their shares crash more than 50%. Rigel started 2008 on the right foot after a 200% jump in a single day last December, following impressive data for the company   s...</description>
 <pubDate>Mon, 10 Nov 2008 05:48:05 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1145376?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Rigel Pharmaceuticals: Biotech Crisis or Opportunity?</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1145584?rsstype=tag&amp;tag=pfe</link>
 <description>The past two weeks were anything but easy for Rigel   s (RIGL) shareholders, who saw their shares crash more than 50%. Rigel started 2008 on the right foot after a 200% jump in a single day last December, following impressive data for the company   s...</description>
 <pubDate>Mon, 10 Nov 2008 05:48:05 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1145584?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>China Bio in Review: More Fallout from Economic Crisis</title>
 <link>http://www.inveslogic.com/sectors/directory/china-stock-blog/1145059?rsstype=tag&amp;tag=pfe</link>
 <description>Ramifications from the worldwide economic crisis continued to seep into the world of China biotech last week. Most notably, Charles River Labs (CRL) noted that more and more of its contract research clients are postponing scheduled studies into next ...</description>
 <pubDate>Sun, 09 Nov 2008 06:05:22 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/china-stock-blog/1145059?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>China Bio in Review: More Fallout from Economic Crisis</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1145068?rsstype=tag&amp;tag=pfe</link>
 <description>Ramifications from the worldwide economic crisis continued to seep into the world of China biotech last week. Most notably, Charles River Labs (CRL) noted that more and more of its contract research clients are postponing scheduled studies into next ...</description>
 <pubDate>Sun, 09 Nov 2008 06:05:22 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1145068?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Dow Price Targets</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1143220?rsstype=tag&amp;tag=pfe</link>
 <description>Below we highlight consensus analyst price targets for the 30 stocks that make up the Dow Jones Industrial Average. As shown, Alcoa&#039;s (AA) price target is currently the highest above its actual price at 52%. AA is trailed by [[HPQ]] and [[INTC]] with...</description>
 <pubDate>Tue, 04 Nov 2008 17:17:32 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1143220?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Not Running Out to Buy Shares in Pfizer</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1142570?rsstype=tag&amp;tag=pfe</link>
 <description>I shouldn&#039;t pick on Jeff Kindler, because I wouldn&#039;t want to be CEO of Pfizer (PFE), not the least little bit. But he gave an interview recently to the Financial Times, who asked him (naturally) about the Lipitor patent expiration. His answer: We&#039;re ...</description>
 <pubDate>Mon, 03 Nov 2008 12:36:08 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1142570?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>A Buy &amp; Hold Forever Dividend Stock Portfolio</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1142461?rsstype=tag&amp;tag=pfe</link>
 <description>This year&#039;s market turbulence has many investors calling the buy and hold strategy dead. Let&#039;s prove them wrong. My musings (here and here) on holding dividend paying stocks forever have inspired me to make a new, all dividend paying stock model port...</description>
 <pubDate>Mon, 03 Nov 2008 08:10:49 -0500</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1142461?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>3 Lower Risk Stocks: Pfizer, Analog Devices, Chevron</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1141056?rsstype=tag&amp;tag=pfe</link>
 <description>As simple as    buy low, sell high    sounds, events and sentiments seem to conspire to get us to do just the opposite. Stocks are cheaper than they have been for a long time. The S&amp;P 500 index, currently at 930 points, needs to climb 18% to reach th...</description>
 <pubDate>Thu, 30 Oct 2008 05:17:44 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1141056?rsstype=tag&amp;tag=pfe</guid>
</item>
<item>
 <title>Buying Aggressively, As Per Ben Graham</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1140029?rsstype=tag&amp;tag=pfe</link>
 <description>Benjamin Graham, the teacher and mentor of Warren Buffett, wrote two seminal tomes on value investing called Security Analysis in 1934 and The Intelligent Investor  in 1949.  I  was reading The Intelligent Investor  at a time when the bear market fol...</description>
 <pubDate>Tue, 28 Oct 2008 06:03:12 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1140029?rsstype=tag&amp;tag=pfe</guid>
</item>
</channel>
</rss>
